| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.1 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |